{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T11:30:48Z","timestamp":1794569448906,"version":"4.9.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T00:00:00Z","timestamp":1648425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T00:00:00Z","timestamp":1648425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Pompe disease (PD) is a disorder of glycogen metabolism conditioning a progressive and life conditioning myopathy. Enzyme replacement therapy (ERT) is currently the best treatment option for PD, but is not resolutive. While other potential therapeutic approaches have been reported before, these have never been tried as co- treatments. L-alanine oral supplementation (LAOS) has been proven to reduce muscle breakdown: we hereby report the first case of supplementation on a PD patient on ERT.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>F. is a 9 y.o. infantile onset Pompe Disease (IOPD) girl ERT-treated since age 1 developing a progressive myopathy. We started her on LAOS and performed assessments at baseline, 6 and 9\u00a0months. At baseline, F.\u2019s weight, height and BMI were within normal ranges, while body composition showed low fat mass -FM and high resting energy expenditure\u2014REE levels. After LAOS, a progressive FM increase and REE reduction could be observed both at 6 and 9\u00a0months.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>ERT is not curative for PD patients thus additional treatments could be considered to improve outcomes. Our patient showed physical signs of inability to accumulate energy when exclusively on ERT, while FM increase and REE reduction occurred when supplemented with LAOS, likely reflecting anabolic pathways\u2019 implementation. This is the first case reporting potential LAOS benefits in PD-on ERT patients. Longitudinal case control studies are yet needed to evaluate possible efficacy of combined LAOS And ERT treatment in PD patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13052-022-01249-y","type":"journal-article","created":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T23:04:02Z","timestamp":1648508642000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["L-alanine supplementation in Pompe disease (IOPD): a potential therapeutic implementation for patients on ERT? A case report"],"prefix":"10.1186","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7703-8635","authenticated-orcid":false,"given":"Valentina","family":"Rovelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juri","family":"Zuvadelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Piotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Scopari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice Re","family":"Dionigi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittoria","family":"Ercoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Paci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziella","family":"Cefalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Salvatici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Banderali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,28]]},"reference":[{"key":"1249_CR1","unstructured":"A.J.J. Reuser, R. Hirschhorn, M.A. Kroos, Pompe Disease: Glycogen Storage Disease Type II, Acid \u03b1-Glucosidase (Acid Maltase) Deficiency, in: D.L. Valle, S. Antonarakis, A. Ballabio, A.L. Beaudet, G.A. Mitchell, The Online Metabolic and Molecular Bases of Inherited Disease. The McGraw-Hill Companies (2001), 3389\u20133420 https:\/\/ommbid.mhmedical.com\/content.aspx?bookid=2709&sectionid=225890450)."},{"key":"1249_CR2","doi-asserted-by":"publisher","first-page":"278","DOI":"10.21037\/atm.2019.04.13","volume":"7","author":"P Peruzzo","year":"2019","unstructured":"Peruzzo P, Pavan E, Dardis A. Molecular genetics of Pompe disease: a comprehensive overview. Ann Transl Med. 2019;7:278. https:\/\/doi.org\/10.21037\/atm.2019.04.13.","journal-title":"Ann Transl Med"},{"key":"1249_CR3","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/s0140-6736(00)02533-2","volume":"356","author":"H Van den Hout","year":"2000","unstructured":"Van den Hout H, Reuser AJ, Vulto AG, Loonen MC, Cromme-Dijkhuis A, Van der Ploeg AT. Recombinant human alpha-glucosidase from rabbit milk in Pompe patients. Lancet. 2000;356:397\u20138. https:\/\/doi.org\/10.1016\/s0140-6736(00)02533-2.","journal-title":"Lancet"},{"key":"1249_CR4","doi-asserted-by":"publisher","first-page":"8861","DOI":"10.1073\/pnas.96.16.8861","volume":"96","author":"A Amalfitano","year":"1999","unstructured":"Amalfitano A, McVie-Wylie AJ, Hu H, et al. Systemic correction of the muscle disorder glycogen storage disease type II after hepatic targeting of a modified adenovirus vector encoding human acid-alpha-glucosidase. Proc Natl Acad Sci USA. 1999;96:8861\u20136. https:\/\/doi.org\/10.1073\/pnas.96.16.8861.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1249_CR5","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.nurt.2008.08.009","volume":"5","author":"B Schoser","year":"2008","unstructured":"Schoser B, Hill V, Raben N. Therapeutic approaches in glycogen storage disease type II\/Pompe Disease. Neurotherapeutics. 2008;5:569\u201378. https:\/\/doi.org\/10.1016\/j.nurt.2008.08.009.","journal-title":"Neurotherapeutics"},{"key":"1249_CR6","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1212\/wnl.33.1.34","volume":"33","author":"AE Slonim","year":"1983","unstructured":"Slonim AE, Coleman RA, McElligot MA, et al. Improvement of muscle function in acid maltase deficiency by high-protein therapy. Neurology. 1983;33:34\u20138. https:\/\/doi.org\/10.1212\/wnl.33.1.34.","journal-title":"Neurology"},{"key":"1249_CR7","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/mus.20665","volume":"35","author":"AE Slonim","year":"2007","unstructured":"Slonim AE, Bulone L, Goldberg T, et al. Modification of the natural history of adult-onset acid maltase deficiency by nutrition and exercise therapy. Muscle Nerve. 2007;35:70\u20137. https:\/\/doi.org\/10.1002\/mus.20665.","journal-title":"Muscle Nerve"},{"key":"1249_CR8","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1136\/jnnp.52.8.954","volume":"52","author":"AM Umpleby","year":"1989","unstructured":"Umpleby AM, Trend PS, Chubb D, et al. The effect of a high protein diet on leucine and alanine turnover in acid maltase deficiency. J Neurol Neurosurg Psychiatry. 1989;52:954\u201361. https:\/\/doi.org\/10.1136\/jnnp.52.8.954.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1249_CR9","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1177\/0148607189013003321","volume":"13","author":"HE Demey","year":"1989","unstructured":"Demey HE, Van Meerbeeck JP, Vandewoude MF, Prov\u00e9 AM, Martin JJ, Bossaert LL. Respiratory insufficiency in acid maltase deficiency: the effect of high protein diet. J Parenter Enteral Nutr. 1989;13:321\u20133. https:\/\/doi.org\/10.1177\/0148607189013003321.","journal-title":"J Parenter Enteral Nutr"},{"key":"1249_CR10","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/s41574-018-0062-9","volume":"14","author":"JA Batsis","year":"2018","unstructured":"Batsis JA, Villareal DT. Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies. Nat Rev Endocrinol. 2018;14:513\u201337. https:\/\/doi.org\/10.1038\/s41574-018-0062-9.","journal-title":"Nat Rev Endocrinol"},{"key":"1249_CR11","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1203\/00006450-198501000-00023","volume":"19","author":"DG Kelts","year":"1985","unstructured":"Kelts DG, Ney D, Bay C, Saudubray JM, Nyhan WL. Studies on requirements for amino acids in infants with disorders of amino acid metabolism, I. Effect of alanine. Pediatr Res. 1985;19:86\u201391. https:\/\/doi.org\/10.1203\/00006450-198501000-00023.","journal-title":"Pediatr Res"},{"key":"1249_CR12","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1212\/wnl.55.5.710","volume":"55","author":"OA Bodamer","year":"2000","unstructured":"Bodamer OA, Halliday D, Leonard JV. The effects of l-alanine supplementation in late-onset glycogen storage disease type II. Neurol. 2000;55:710\u20132. https:\/\/doi.org\/10.1212\/wnl.55.5.710.","journal-title":"Neurol"},{"key":"1249_CR13","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/s0887-8994(02)00413-7","volume":"27","author":"OA Bodamer","year":"2002","unstructured":"Bodamer OA, Haas D, Hermans MM, Reuser AJ, Hoffmann GF. L-alanine supplementation in late infantile glycogen storage disease type II. Pediatr Neurol. 2002;27:145\u20136. https:\/\/doi.org\/10.1016\/s0887-8994(02)00413-7.","journal-title":"Pediatr Neurol"},{"key":"1249_CR14","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/s10545-018-0243-7","volume":"41","author":"C Semplicini","year":"2018","unstructured":"Semplicini C, Letard P, De Antonio M, et al. Late-onset Pompe disease in France: molecular features and epidemiology from a nationwide study. J Inherit Metab Dis. 2018;41:937\u201346. https:\/\/doi.org\/10.1007\/s10545-018-0243-7.","journal-title":"J Inherit Metab Dis"},{"key":"1249_CR15","volume-title":"Nutrients and energy reference intake for Italian Population, 4th Rev. SINU (Italian Sociaety of Human Nutrition)","author":"LARN","year":"2014","unstructured":"LARN. Nutrients and energy reference intake for Italian Population, 4th Rev. SINU (Italian Sociaety of Human Nutrition). 2014."},{"key":"1249_CR16","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/0002-8223(94)90158-9","volume":"94","author":"PB Crawford","year":"1994","unstructured":"Crawford PB, Obarzanek E, Morrison J, Sabry ZI. Comparative advantage of 3-day food records over 24-hour recall and 5-day food frequency validated by observation of 9- and 10-year-old girls. J Am Diet Assoc. 1994;94:626\u201330. https:\/\/doi.org\/10.1016\/0002-8223(94)90158-9.","journal-title":"J Am Diet Assoc"},{"key":"1249_CR17","unstructured":"2007 WHO Reference (Growth reference 5\u201319 years). Accessed 13 Jan 2021. https:\/\/www.who.int\/growthref\/en\/"},{"key":"1249_CR18","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/sj.ijo.0803232","volume":"30","author":"HD McCarthy","year":"2006","unstructured":"McCarthy HD, Cole TJ, Fry T, Jebb SA, Prentice AM. Body fat reference curves for children. Int J Obes (Lond). 2006;30:598\u2013602. https:\/\/doi.org\/10.1038\/sj.ijo.0803232.","journal-title":"Int J Obes (Lond)"},{"key":"1249_CR19","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/j.jand.2015.04.003","volume":"115","author":"S Fullmer","year":"2015","unstructured":"Fullmer S, Benson-Davies S, Earthman CP, et al. Evidence analysis library review of best practices for performing indirect calorimetry in healthy and non-critically ill individuals. J Acad Nutr Diet. 2015;115:1417\u201346. https:\/\/doi.org\/10.1016\/j.jand.2015.04.003.","journal-title":"J Acad Nutr Diet"},{"key":"1249_CR20","first-page":"1","volume":"724","author":"Energy and protein requirements","year":"1985","unstructured":"Energy and protein requirements. Report of a joint FAO\/WHO\/UNU Expert Consultation. World Health Organ Tech Rep Ser. 1985;724:1\u2013206.","journal-title":"World Health Organ Tech Rep Ser"},{"key":"1249_CR21","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3389\/fcell.2019.00179","volume":"7","author":"AM Palhegyi","year":"2019","unstructured":"Palhegyi AM, Seranova E, Dimova S, Hoque S, Sarkar S. Biomedical Implications of Autophagy in Macromolecule Storage Disorders. Front Cell Dev Biol. 2019;7:179. https:\/\/doi.org\/10.3389\/fcell.2019.00179.","journal-title":"Front Cell Dev Biol"},{"key":"1249_CR22","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1016\/j.ymthe.2018.04.025","volume":"26","author":"JA Lim","year":"2018","unstructured":"Lim JA, Sun B, Puertollano R, Raben N. Therapeutic Benefit of Autophagy Modulation in Pompe Disease. Mol Ther. 2018;26:1783\u201396. https:\/\/doi.org\/10.1016\/j.ymthe.2018.04.025.","journal-title":"Mol Ther"},{"key":"1249_CR23","unstructured":"K. Esposito, M.R. Improta, D. Giugliano, S2.5 The nutritional approach to Pompe disease,\u00a0Acta Myol. 30 (2011) 208\u2013209."},{"key":"1249_CR24","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s10545-006-0238-7","volume":"29","author":"HR Mundy","year":"2006","unstructured":"Mundy HR, Williams JE, Cousins AJ, Lee PJ. The effect of L-alanine therapy in a patient with adult onset glycogen storage disease type II. J Inherit Metab Dis. 2006;29:226\u20139. https:\/\/doi.org\/10.1007\/s10545-006-0238-7.","journal-title":"J Inherit Metab Dis"},{"key":"1249_CR25","doi-asserted-by":"publisher","first-page":"5229","DOI":"10.12659\/MSM.914783","volume":"25","author":"L Yang","year":"2019","unstructured":"Yang L, Zhu Y, Huang JA, Jin J, Zhang X. A Low Lean-to-Fat Ratio Reduces the Risk of Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Patients with a Normal or Low Body Mass Index. Med Sci Monit. 2019;25:5229\u201336. https:\/\/doi.org\/10.12659\/MSM.914783.","journal-title":"Med Sci Monit"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-022-01249-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-022-01249-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-022-01249-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T23:09:23Z","timestamp":1648508963000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-022-01249-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,28]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1249"],"URL":"https:\/\/doi.org\/10.1186\/s13052-022-01249-y","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,28]]},"assertion":[{"value":"20 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in this study were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This study was also approved by the ERB of the Clinical Department of Pediatrics of San Paolo Hospital, University of Milan.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"48"}}